Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications

References

• CroxtallJDGanciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers)Drugs201171560361021443283
   PubMed Web of Science ®Google Scholar
• LiesegangTJHerpes simplex virus epidemiology and ocular importanceCornea200120111311188989
   PubMed Web of Science ®Google Scholar
• SahinAHamrahPAcute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?Ophthalmol Eye Dis20124233423650455
   PubMedGoogle Scholar
• ColinJGanciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpesClin Ophthalmol20071444145319668521
   PubMedGoogle Scholar
• KaufmanHEHawWHGanciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitisCurr Eye Res201237765466022607463
   PubMed Web of Science ®Google Scholar
• HlinomazováZLoukotováVHoráčkováMŠerýOThe treatment of HSV1 ocular infections using quantitative real-time PCR resultsActa Ophthalmol201290545646020553233
   PubMed Web of Science ®Google Scholar
• TabbaraKFAl BalushiNTopical ganciclovir in the treatment of acute herpetic keratitisClin Ophthalmol2010490591220823931
   PubMedGoogle Scholar
• TabbaraKFTreatment of herpetic keratitisOphthalmology20051129164016139674
   PubMed Web of Science ®Google Scholar
• XuFSternbergMRKottiriBJTrends in herpes simplex virus type 1 and type 2 seroprevalence in the United StatesJAMA2006296896497316926356
   PubMed Web of Science ®Google Scholar
• LiesegangTJEpidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950–1982Trans Am Ophthalmol Soc1988866887242979036
   PubMedGoogle Scholar
• Zirgan^® [patient’s guide]RochesterBausch and Lomb Incorporated2012 Available from: http://www.zirgan-info.com/healthcare_professionals/flipbooks/zirgan_detail_aid_fb/index.html
   Google Scholar
• LairsonDRBegleyCEReynoldsTFWilhelmusKRPrevention of herpes simplex virus eye disease: a cost-effectiveness analysisArch Ophthalmol2003121110812523894
   PubMedGoogle Scholar
• YoungRCHodgeDOLiesegangTJBaratzKHIncidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976–2007: the effect of oral antiviral prophylaxisArch Ophthalmol201012891178118320837803
   PubMedGoogle Scholar
• ColinJHohHBEastyDLGanciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitisCornea19971643933999220235
   PubMed Web of Science ®Google Scholar
• LabetoulleMThe latest in herpes simplex keratitis therapyJ Fr Ophtalmol200427554755715179314
   PubMed Web of Science ®Google Scholar
• ChingSSTFederRSHindmanHBWilhelmusKRMahFSHerpes Simplex Virus Epithelial Keratitis, Preferred Practice Pattern®Clinical QuestionsAmerican Academy of Ophthalmology201218
   Google Scholar
• MorissetteGFlamandLHerpesviruses and chromosomal integrationJ Virol20108423121001210920844040
   PubMed Web of Science ®Google Scholar
• Robinet-CombesAColinJAtteintes herpétiques du segment antérieurParis, FranceEditions Techniques1993 Encycl Med Chir, Ophtalmol, 21-200 D-20 (7 p)
   Google Scholar
• FarooqAVShuklaDCorneal latency and transmission of herpes simplex virus-1Future Virol20116110110821436960
   PubMed Web of Science ®Google Scholar
• Drugs: GanciclovirAIDSinfo Drug DatabaseUS Department of Health and Human Resources2013
   Google Scholar
• MellerickDMFraserNWPhysical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal stateVirology198715822652753035783
   PubMed Web of Science ®Google Scholar
• DeshmaneSLFraserNWDuring latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structureJ Virol19896329439472536115
   PubMed Web of Science ®Google Scholar
• HerpesvirusesBrooksGFCarrollKCButelJSMorseSAMietznerTAJawetz, Melnick, and Adelberg’s Medical Microbiology, 26eNew YorkMcGraw-Hill2013 Available from: http://accessmedicine.mhmedical.com.ezproxy.hsclib.sunysb.edu/content.aspx?bookid=504&Sectionid=40999955Accessed February 7, 2014
   Google Scholar
• SuthpinJEDanaMRFlorakisGJHammersmithKReidyJJLopatynskyMBasic and Clinical Science Course, External Disease and Cornea section 8San Francisco: American Academy of Ophthalmology200614324
   Google Scholar
• TomaHSMurinaATAreauxRGJrOcular HSV-1 latency, reactivation and recurrent diseaseSemin Ophthalmol200823424927318584563
   PubMedGoogle Scholar
• AsbellPAValacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomyTrans Am Ophthalmol Soc20009828530311190029
   PubMedGoogle Scholar
• DarougarSWishartMSViswalingamNDEpidemiological and clinical features of primary herpes simplex virus ocular infectionBr J Ophthalmol1985691263965025
   PubMed Web of Science ®Google Scholar
• LiesegangTJMeltonLJ3rdDalyPJIlstrupDMEpidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982Arch Ophthalmol19891078115511592787981
   PubMedGoogle Scholar
• WishartMSDarougarSViswalingamNDRecurrent herpes simplex virus ocular infection: epidemiological and clinical featuresBr J Ophthalmol19877196696723663560
   PubMed Web of Science ®Google Scholar
• ObaraYFurutaYTakasuTDistribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridizationJ Med Virol19975221361429179758
   PubMed Web of Science ®Google Scholar
• ZhengXReactivation and donor-host transmission of herpes simplex virus after corneal transplantationCornea200221Suppl 7S90S9312484706
   PubMed Web of Science ®Google Scholar
• RemeijerLMaertzdorfJDoornenbalPVerjansGMOsterhausADHerpes simplex virus 1 transmission through corneal transplantationLancet2001357925444211273067
   PubMed Web of Science ®Google Scholar
• KennedyDPClementCArceneauxRLBhattacharjeePSHuqTSHillJMOcular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?Cornea201130325125921304287
   PubMed Web of Science ®Google Scholar
• DuTZhouGRoizmanBModulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3Proc Natl Acad Sci U S A201311028E2621E262823788661
   PubMed Web of Science ®Google Scholar
• ChidaYMaoXDoes psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studiesBrain Behav Immun200923791792519409481
   PubMed Web of Science ®Google Scholar
• LudemaCColeSRPooleCSmithJSSchoenbachVJWilhelmusKRAssociation between unprotected ultraviolet radiation exposurev and recurrence of ocular herpes simplex virusAm J Epidemiol2014179220821524142918
   PubMed Web of Science ®Google Scholar
• MucciJJUtzVMGalorAFeuerWJengBHRecurrence rates of herpes simplex virus keratitis in contact lens and non-contact lens wearersEye Contact Lens200935418518719502988
   PubMed Web of Science ®Google Scholar
• No authors listedPsychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study GroupArch Ophthalmol2000118121617162511115255
   PubMedGoogle Scholar
• RemeijerLDoornenbalPGeerardsAJRijneveldWABeekhuisWHNewly acquired herpes simplex virus keratitis after penetrating keratoplastyOphthalmology199710446486529111258
   PubMed Web of Science ®Google Scholar
• BorderieVMMeritetJFChaumeilCCulture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of herpes diseaseCornea200423211812415075879
   PubMed Web of Science ®Google Scholar
• LevyJLapid-GortzakRKlempererILifshitzTHerpes simplex virus keratitis after laser in situ keratomilieusisJ Refract Surg200521440040216128340
   PubMed Web of Science ®Google Scholar
• No authors listedPredictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study GroupCornea200120212312811248812
   PubMed Web of Science ®Google Scholar
• GhoshehFRCremonaFARapuanoCJTrends in penetrating keratoplasty in the United States 1980–2005Int Ophthalmol200828314715318084724
   PubMedGoogle Scholar
• DarlingtonJKAdreanSDSchwabIRTrends of penetrating keratoplasty in the United States from 1980 to 2004Ophthalmology2006113122171217516996602
   PubMed Web of Science ®Google Scholar
• LiuESlomovicARIndications for penetrating keratoplasty in Canada, 1986–1995Cornea19971644144199220238
   PubMed Web of Science ®Google Scholar
• LindquistTDMcGlothanJSRotkisWMChandlerJWIndications for penetrating keratoplasty: 1980–1988Cornea19911032102162055026
   PubMed Web of Science ®Google Scholar
• YahalomCMechoulamHSolomonARaiskupFDPeerJFrucht-PeryJForty years of changing indications in penetrating keratoplasty in IsraelCornea200524325625815778594
   PubMed Web of Science ®Google Scholar
• SanoFTDantasPESilvinoWRTrends in the indications for penetrating keratoplastyArq Bras Oftalmol2008713400404 Portuguese18641829
   PubMed Web of Science ®Google Scholar
• RobinJBGindiJJKohKAn update of the indications for penetrating keratoplasty. 1979 through 1983Arch Ophthalmol1986104187893510613
   PubMedGoogle Scholar
• InoueYShimomuraYFukudaMMulticentre clinical study of the herpes simplex virus immunochromatographic assay kit for the diagnosis of herpetic epithelial keratitisBr J Ophthalmol20139791108111223087417
   PubMed Web of Science ®Google Scholar
• EdwardsMCloverGMBrookesNPendergrastDChaulkJMcGheeCNIndications for corneal transplantation in New Zealand: 1991–1999Cornea200221215215511862084
   PubMed Web of Science ®Google Scholar
• WilliamsKALoweMTBartlettCMKellyLCosterDJThe Australian Corneal Graft Registry 2007 Report2007
   Google Scholar
• PatelNPKimTRapuanoCJCohenEJLaibsonPRIndications for and outcomes of repeat penetrating keratoplasty, 1989–1995Ophthalmology2000107471972410768334
   PubMed Web of Science ®Google Scholar
• AydemirOTurkcuogluPBulutYKalkanAThe relationship of graft survival and herpes simplex virus latency in recipient corneal buttonsClin Ophthalmol20071212713119668501
   PubMedGoogle Scholar
• De KeselRJKoppenCIevenMZeyenTPrimary graft failure caused by herpes simplex virus type 1Cornea200120218719011248827
   PubMed Web of Science ®Google Scholar
• BiswasSSureshPBonshekRECorbittGTulloABRidgwayAEGraft failure in human donor corneas due to transmission of herpes simplex virusBr J Ophthalmol200084770170510873977
   PubMed Web of Science ®Google Scholar
• FosterCSGanciclovir gel – a new topical treatment for herpetic keratitisUS Ophthalmic Rev200735256
   Google Scholar
• ShearerDRBourneWMSevere ocular anterior segment ischemia after long-term trifluridine treatment for presumed herpetic keratitisAm J Ophthalmol199010933463472106789
   PubMed Web of Science ®Google Scholar
• CastelaNVermerieNChastFGanciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacyJ Ocul Pharmacol19941024394518083563
   PubMedGoogle Scholar
• LassJHLangstonRHFosterCSPavan-LangstonDAntiviral medications and corneal wound healingAntiviral Res1984431431576476819
   PubMed Web of Science ®Google Scholar
• WilhelmusKRAntiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisCochrane Database Syst Rev201012CD00289821154352
   PubMed Web of Science ®Google Scholar
• UdellIJTrifluridine-associated conjunctival cicatrizationAm J Ophthalmol19859933633643919588
   PubMed Web of Science ®Google Scholar
• LassJHThoftRADohlmanCHIdoxuridine-induced conjunctival cicatrizationArch Ophthalmol198310157477506342581
   PubMedGoogle Scholar
• MaudgalPCVan DammeBMissottenLCorneal epithelial dysplasia after trifluridine useGraefes Arch Clin Exp Ophthalmol198322016126403411
   PubMed Web of Science ®Google Scholar
• HohHBHurleyCClaoueCRandomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre studyBr J Ophthalmol19968021401438814744
   PubMed Web of Science ®Google Scholar
• GuessSStoneDUChodoshJEvidence-based treatment of herpes simplex virus keratitis: a systematic reviewOcul Surf20075324025017660897
   PubMed Web of Science ®Google Scholar
• CollumLMAkhtarJMcGettrickPOral acyclovir in herpetic keratitisTrans Ophthalmol Soc U K1985104Pt 66296323909544
   PubMedGoogle Scholar
• WilhelmusKRThe treatment of herpes simplex virus epithelial keratitisTrans Am Ophthalmol Soc20009850553211190039
   PubMedGoogle Scholar
• SozenEAvundukAMAkyolNComparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trialChemotherapy2006521293116340195
   PubMed Web of Science ®Google Scholar
• BarronBAGeeLHauckWWHerpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitisOphthalmology199410112187118827997323
   PubMed Web of Science ®Google Scholar
• No authors listedAcyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study GroupN Engl J Med199833953003069696640
   PubMed Web of Science ®Google Scholar
• No authors listedOral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study GroupArch Ophthalmol200011881030103610922194
   PubMedGoogle Scholar
• SimonALPavan-LangstonDLong-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without graftsOphthalmology1996103913991404 discussion 1395–14048841297
   PubMed Web of Science ®Google Scholar
• UchoaUBRezendeRACarrascoMARapuanoCJLaibsonPRCohenEJLong-term acyclovir use to prevent recurrent ocular herpes simplex virus infectionArch Ophthalmol2003121121702170414662588
   PubMedGoogle Scholar
• O’BrienWJSegundoAPGuyJDornEMTaylorJLHerpetic stromal disease: response to acyclovir/steroid therapyActa Ophthalmol Scand19967432652708828724
   PubMedGoogle Scholar
• Zirgan^® [prescribing information]RochesterBausch and Lomb Incorporated2010 Available from: http://www.bausch.com/-/m/BL/United%20States/Files/Package%20Inserts/Pharma/zirganpackageinsert.pdfAccessed April 16, 2014
   Google Scholar
• TomicicMTBeyEWutzlerPThustRKainaBComparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovirMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis20025051111
   PubMed Web of Science ®Google Scholar
• ChengYCHuangESLinJCUnique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1Proc Natl Acad Sci U S A1983809276727706302704
   PubMed Web of Science ®Google Scholar
• ShawMMGurrWKWattsPALittlerEFieldHJGanciclovir and penciclovir, but not acyclovir, induce apoptosis in herpes simplex virus thymidine kinase-transformed baby hamster kidney cellsAntivir Chem Chemother200112317518612959326
   PubMedGoogle Scholar
• ChunYSParkNHEffect of ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] on viral DNA and protein synthesis in cells infected with herpes simplex virusAntimicrob Agents Chemother19873123493513032100
   PubMed Web of Science ®Google Scholar
• CheeSPJapATreatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitisGraefes Arch Clin Exp Ophthalmol2012250338338921892696
   PubMed Web of Science ®Google Scholar
• KandoriMInoueTTakamatsuFPrevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirusOphthalmology2010117221622219969369
   PubMed Web of Science ®Google Scholar
• SuCCWangIJChenWLLinCPHisBHuFRTopical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplastyClin Experiment Ophthalmol201341433934723009154
   PubMed Web of Science ®Google Scholar
• WangSCTsaiILLinHCKuoLLTsaiCYLiouSWRecurrent cytomegalovirus corneal endotheliitis after penetrating keratoplasty. Eur J OphthalmolMarch–April2010202457459
   Google Scholar
• FauldsDHeelRCGanciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infectionsDrugs19903945976382161731
   PubMed Web of Science ®Google Scholar
• WangXXuJJLeQHWangYWangWTClinical assessment of oral ganciclovir capsules on the treatment of herpes simplex keratitisZhonghua Yan Ke Za Zhi20104611994999 Chinese21211295
   PubMedGoogle Scholar
• SullivanVTalaricoCLStanatSCDavisMCoenDMBironKKA protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cellsNature199235863821621641319560
   PubMed Web of Science ®Google Scholar
• HamzehFMLietmanPSIntranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovirAntimicrob Agents Chemother1991359181818231659307
   PubMed Web of Science ®Google Scholar
• CrumpackerCSGanciclovirN Engl J Med1996335107217298786764
   PubMed Web of Science ®Google Scholar
• LeibowitzHMWaringGOCorneal Disorders: Clinical Diagnosis and ManagementPhiladelphia, PASaunders1998599600746748
   Google Scholar
• Virgan^® [summary of product characteristics]MacclesfieldSpectrum Théa Pharmaceuticals2003
   Google Scholar
• Transphyto1993bEtude clinique comparative multicentrique de l′effet del′instillation de GV 550 dans l’herpes cornéen superficielClermont- Ferrand, FranceRapport clinique No 44.GV 550/12.90-46. GV 550/07.90. Dossier d′AMM
   Google Scholar
• Transphyto1993cEtude clinique comparative randomisée en simple insu de l′effet de l′instillation de ganciclovir gel ophtalmique dans le traitement de l′herpes cornéen superficielClermont-Ferrand, FranceRapport clinique No 47.GV 550/09.90. Dossier d′AMM
   Google Scholar
• PouliquenPElenaPPMalecazeFLuyckxJLanoueAGoldschmidtPAssessment of the safety and local pharmacokinetics of 0.15% gel of ganciclovir (Virgan®) in healthy volunteers. ARVO meeting 1996; Fort Lauderdale, FL, USAInvest Ophthalmol Vis Sci199637S313 abstract 1431
   Web of Science ®Google Scholar
• TirucheraiGSDiasCMitraAKCorneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug designJ Ocul Pharmacol Ther200218653554812537680
   PubMed Web of Science ®Google Scholar
• TrousdaleMDNesburnABWilleyDETaaidHEfficacy of BW759 (9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine) against herpes simplex virus type 1 keratitis in rabbitsCurr Eye Res198438100710156333319
   PubMed Web of Science ®Google Scholar
• LoweEJiangSProkschJWRapid ocular penetration of ganciclovir with topical administration of Zirgan^® to rabbitsPoster presented at: 2008 Annual Meeting of the Association for Research in Vision and OphthalmologyApril 30–May 5, 2011Fort Lauderdale, FL
   Google Scholar
• MajumdarSTirucheraiGSPalDMitraAKFunctional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit corneaAAPS PharmSci2003527285
   Google Scholar
• NaitoTNittaKKinouchiYShiotaHMimuraYEffects of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) eye drops and cyclosporine eye drops in the treatment of herpetic stromal keratitis in rabbitsCurr Eye Res199110Suppl2012031650668
   PubMedGoogle Scholar
• ShiotaHNaitoTMimuraYAnti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) in rabbit corneaCurr Eye Res1987612412453030645
   PubMed Web of Science ®Google Scholar
• Clirophta Evaluation de la tolérance locale chez le volontaire sain, après instillations multiples d’un gel ophtalmique de ganciclovir 0,15%, VirganNice, FranceRapport clinique Virgan/F-94-01. Dossier d’AMM1994
   Google Scholar
• Clirophta Cinétique du ganciclovir dans les larmes, après instillations multiples d’un gel ophtalmique de ganciclovir 0,15%, Virgan, chez le volontaire sainNice, FranceRapport clinique Virgan/F-94-02. Dossier d’AMM1994
   Google Scholar
• KaufmanHEData from Trials Evaluating Ganciclovir Ophthalmic Gel 0.15% and Acyclovir Ophthalmic Ointment 3.0% for Herpetic KeratitisAAO Annual MeetingAtlanta, GA, USANovember 9, 2008P0054
   Google Scholar
• TraugottKNational Drug Monograph: Ganciclovir Ophthalmic Gel 0.15% (Zirgan™)VA Pharmacy Benefits Management Services52010
   Google Scholar
• HoldinessMRContact dermatitis from topical antiviral drugsContact Dermatitis200144526526911298689
   PubMed Web of Science ®Google Scholar
• LorenziSD’AntuonoAIorizzoMTostiASkin rash and splinter hemorrhages from ganciclovirJ Dermatolog Treat200314317717814522628
   PubMedGoogle Scholar
• VarnellEDKaufmanHEComparison of Ganciclovir Ophthalmic Gel and Trifluridine Drops for the Treatment of Experimental Herpetic KeratitisInvest Ophthalmol Vis Sci200849 E-Abstract 2491
   Google Scholar
• VarnellEDKaufmanHEComparison of ganciclovir ophthalmic gel and trifluridine drops for the treatment of experimental herpes keratitisPaper presented at: 2011 Annual Meeting of the Association for Research in Vision and OphthalmologyApril 30 to May 5, 2011Fort Lauderdale, FL
   Google Scholar
• GordonYJCaponeASheppardJGordonARomanowskiEAraullo-CruzT2′-nor-cGMP, a new cyclic derivative of 2′NDG, inhibits HSV-1 replication in vitro and in the mouse keratitis modelCurr Eye Res1987612472533030646
   PubMed Web of Science ®Google Scholar
• CharlesSJGrayJJOcular herpes simplex virus infections: reduced sensitivity to acyclovir in primary diseaseBr J Ophthalmol19907452862882162190
   PubMed Web of Science ®Google Scholar
• LeeSYHerpes simplex virus ocular infectionsDrugs Today (Barc)199834324124915094853
   PubMed Web of Science ®Google Scholar
• LaibsonPRResistant herpes simplex keratitisClin Experiment Ophthalmol201038322722820447115
   PubMed Web of Science ®Google Scholar
• SupertiFAmmendoliaMMarchettiMNew advances in anti-HSV chemotherapyCurrent medicinal chemistry200815990091118473797
   PubMed Web of Science ®Google Scholar
• ChoongKWalkerNJApelAJWhitbyMAciclovir-resistant herpes keratitisClin Experiment Ophthalmol201038330931320447128
   PubMed Web of Science ®Google Scholar
• LevinMJBaconTHLearyJJResistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patientsClin Infect Dis200439Suppl 5S248S25715494896
   PubMed Web of Science ®Google Scholar
• DuanRde VriesRDOsterhausADRemeijerLVerjansGMAcyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitisJ Infect Dis2008198565966318627246
   PubMed Web of Science ®Google Scholar
• DuanRde VriesRDvan DunJMAcyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitisJ Infect Dis200920091402141419795980
   PubMed Web of Science ®Google Scholar
• BaconTHLevinMJLearyJJSariskyRTSuttonDHerpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyClin Microbiol Rev200316111412812525428
   PubMed Web of Science ®Google Scholar
• YaoYFInoueYKaseTUchihoriYMoriYOhashiYClinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolatesGraefes Arch Clin Exp Ophthalmol1996234Suppl 1S126S1328871163
   PubMedGoogle Scholar
• Drugs; Guidance, Compliance, and Regulatory information; SurveillanceUS Food and Drug Administration updated 11/13/2012. Available from: http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/ucm324693.htmAccessed April 16, 2014
   Google Scholar
• LiuSPavan-LangstonDColbyKAPediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomesOphthalmology2012119102003200822796308
   PubMed Web of Science ®Google Scholar
• SchwartzGSHollandEJOral acyclovir for the management of herpes simplex virus keratitis in childrenOphthalmology2000107227828210690825
   PubMed Web of Science ®Google Scholar
• HsiaoC-HYeungLYehL-KPediatric herpes simplex virus keratitisCornea200928324925319387223
   PubMed Web of Science ®Google Scholar
• ChongE-MWilhelmusKRMatobaAYJonesDBCoatsDKPaysseEAHerpes simplex virus keratitis in childrenAm J Ophthalmol2004138347447515364233
   PubMed Web of Science ®Google Scholar
• No authors listedA controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study GroupArch Ophthalmol19961149106510728790090
   PubMedGoogle Scholar
• TabbaraKFJaradeEFGanciclovir effects in adenoviral keratoconjunctivitisInvest Ophthalmol Vis Sci2001424
   Web of Science ®Google Scholar
• YabikuSTYabikuMMBottósKMAraújoALFreitasDdBelfortRJrGanciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitisArq Bras Oftalmol2011746417421 Portuguese22331114
   PubMed Web of Science ®Google Scholar
• EpsteinSPFernandezKBCarterBMAbdouSAGadariaNAsbellPASafety and efficacy of ganciclovir ophthalmic gel for treatment of adenovirus keratoconjunctivitis utilizing cell culture and animal modelsInv Ophthalmol Vis Sci2012Suppl5346203
   Google Scholar
• UchioETakeuchiSItohNMatsuuraNOhnoSAokiKClinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1Br J Ophthalmol200084996897210966946
   PubMed Web of Science ®Google Scholar
• TrousdaleMDGoldschmidtPLNóbregaRActivity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyesCornea19941354354397995068
   PubMed Web of Science ®Google Scholar
• VérinPMortemousqueBBarachDGanciclovir 0.15% gel, a new treatment in epidemic keratoconjunctivitis (EKC)Ophthalmic Res199729Suppl 112279112262
   PubMedGoogle Scholar
• Lifelong Vision FoundationA Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus ConjunctivitisClinicalTrials.gov [website on the Internet]Bethesda, MDUS National Library of Medicine2012 [updated February 10, 2012]. Available from http://clinicaltrials.gov/ct2/show/NCT01533480?term=NCT01533480&rank=1.NLMidentifier:NCT01533480Accessed March 5, 2014
   Google Scholar
• Adapt Produtos Oftalmológicos LtdaEvaluate the Use of Ganciclovir Gel 03% for the Treatment of Conjunctivitis Caused by AdenovirusClinicalTrials.gov [website on the Internet]Bethesda, MDUS National Library of Medicine2011 [updated May 15, 2012]. Available from http://clinicaltrials.gov/ct2/show/NCT01600365?term=NCT01600365&rank=1. NLMidentifier: NCT01600365Accessed March 5, 2014
   Google Scholar
• YeeRWSiglerSCLawtonAWAldersonGLTrinkleJKLumCTApparent cytomegalovirus epithelial keratitis in a cardiac transplant recipientTransplantation1991515104010431851582
   PubMed Web of Science ®Google Scholar
• WehrlySRManningFJProiaADBurchetteJLFoulksGNCytomegalovirus keratitis after penetrating keratoplastyCornea19951466286338575188
   PubMed Web of Science ®Google Scholar
• WilhelmusKRFontRLLehmannRPCernochPLCytomegalovirus keratitis in acquired immunodeficiency syndromeArch Ophthalmol199611478698728660174
   PubMedGoogle Scholar
• AggarwalSCavalcantiBMPavan-LangstonDTreatment of pseudodendrites in herpes zoster ophthalmicus with topical ganciclovir 0.15% gelCornea201433210911324322809
   PubMed Web of Science ®Google Scholar
• OliverSBubleyGCrumpackerCInhibition of HSV-transformed murine cells by nucleoside analogs, 2′-NDG and 2′-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosidesVirology1985145184932990104
   PubMed Web of Science ®Google Scholar
• VileRGHartIRUse of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNACancer Research19935317386038648395331
   PubMed Web of Science ®Google Scholar
• Chévez-BarriosPChintagumpalaMMielerWResponse of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovirJ Clin Oncol200523317927793516258092
   PubMed Web of Science ®Google Scholar
• SturgesAButtALLaiJEChodishJTopical interferon or surgical excisio for the management of primary ocular surface squamous neoplasiaOphthalmology200811581297130218294690
   PubMed Web of Science ®Google Scholar
• GuptaAMueckeJTreatment of ocular surface squamous neoplasia with Mitomycin CBr J Ophthalmol201094555555820447963
   PubMed Web of Science ®Google Scholar
• KrilisMTsangHCoroneoMTreatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alpha-2b: long-term follow-upOphthalmology2012119101969197322704834
   PubMed Web of Science ®Google Scholar
• WestekemperHFreistuehlerMAnastassiouGChemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinationsBr J Ophthalmol201296459159622275346
   PubMed Web of Science ®Google Scholar
• HeroldTRHintschichCInterferon alpha for the treatment of melanocytic conjunctival lesionsGraefes Arch Clin Exp Ophthalmol2010248111111519756691
   PubMed Web of Science ®Google Scholar
• FingerPTSedeekRWChinKJTopical interferon alpha in the treatment of conjumctival melanoma and priimary acquired melanosis complexAm J Ophthalmol2008145112412917981257
   PubMed Web of Science ®Google Scholar
• McDonaldMBHardtenDRMahFSManagement of epithelial herpetic keratitis: An evidence-based algorithmReport from the Ad-Hoc Committee for the Management of Epithelial Herpetic Keratitis11112012 Available from: http://www.optometricmanagement.com/content/bl/2/b-l_treament-finalnb.pdfAccessed April 16, 2014
   Google Scholar